OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

Antiviral proteins and their uses in therapeutic methods

Recombinant AAVS having useful transcytosis properties

Composition for regulating cell division comprising FCHO1 modulator, and method for regulating cell division using same

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

Compositions and methods for treating a viral infection

METHOD FOR TREATING NEURODEVELOPMENTAL DISORDERS

ENHANCED ORGANOID FORMATION AND INTESTINAL STEM CELL RENEWAL

Nanospheres of SEC14-like proteins and cognate ligands

Pharmaceutical composition comprising Lefty

TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF

Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Alzheimer's Disease

Compositions and methods using a polyphenol for musculoskeletal health

NEURONAL VIABILITY FACTOR AND USE THEREOF

Immunotherapy against melanoma and other cancers

IL-2 superagonists in combination with anti-PD-1 antibodies

Composition for overcoming resistance to EGFR-targeting agent

Compositions comprising an urolithin compound

Adeno-associated virus vector delivery of microRNA-29 and micro-dystrophin to treat muscular dystrophy

Compositions and methods useful in treating Stargardt's disease and other ocular disorders

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Sumoylation of Serca2A and Cardiovascular Disease

GLYCOPEPTIDES AND USES THEREOF

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases

Glucocerebroside treatment of disease

Technology for the Preparation of Microparticles

Drug delivery means

Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy

Compositions Comprising Hypoxia Inducible Factor-1 Alpha and Methods of Using the Same

Compositions and methods for modulating the immune system

Production of oversized adeno-associated vectors

Peptide-based methods for treating neurological injury

Use of AAC-11 inhibitors for the treatment of viral infection

APOMERS

CONTROL AND CHARACTERIZATION OF MEMORY FUNCTION

Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Immunotherapy against melanoma and other cancers

Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system

Methods of treatment using hemopexin compositions

Method of reducing the likelihood of skin cancer in an individual human being

Permanent epigenetic gene silencing

FORMULATION OF MK2 INHIBITOR PEPTIDES

METHODS TO REGULATE POLARIZATION AND ENHANCE FUNCTION OF CELLS

Cytokine modulation

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

TIFA antagonists and their use for treating diseases

Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound

Therapeutic Nanoparticles Having EGFR Ligands and Methods of Making and Using Same

Uterine cancer treatments

Stabilized BCL9 peptides for treatment of aberrant WNT signaling

METHOD FOR OPENING TIGHT JUNCTIONS

Mutant peptides and methods of treating subjects using the same

Gastro-resistant microencapsulates, and uses thereof to stimulate in-vivo ileal GLP-1 release in a mammal

Protein prostheses for mitochondrial diseases or conditions

Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases

MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME

Reconstructed HDL formulation

CASEIN PEPTIDE FOR USE IN THE TREATMENT OF UTERINE INFECTIONS

SDC-2 exosome compositions and methods of isolation and use

Triple combination antibody therapies

Natural tissue scaffolds as tissue fillers

Use of annexin V to reduce the spread of intracellular pathogens

PROTEIN-RICH ENTERAL NUTRITIONAL COMPOSITION CONTAINING A HIGH PROPORTION OF CASEINATES

Compositions and methods for detecting and treating ovarian cancer

Targeted protein degradation

MODULATING THE ALTERNATIVE COMPLEMENT PATHWAY

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

Immunotherapy against several tumors, such as lung cancer, including NSCLC

Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides

Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming

SEMAPHORIN 3A FOR TREATMENT AND PROGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS

Placental tissue composition for for treating cardiac tissue damage

USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT

Modulating the alternative complement pathway

Messenger RNA therapy for the treatment of Friedreich's ataxia

Method of Reducing Injury to Mammalian Cells

Lipid formulations for delivery of messenger RNA

Process for producing a composition for increasing muscle mass

Method of measuring a level of anti-vinculin antibodies in a biological sample

IL2R common gamma chain antibodies

Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid

Methods and compositions for improving glucose metabolism

Compositions and methods for modulating stem cells and uses thereof

TREATMENT OF EYE DISEASE

Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using Apo A-I Milano gene transfer

Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

Adrenomedullin therapy to improve fetal implantation

Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system

Methods and kits for monitoring membranous nephropathy

Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content

Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein

ADENO-ASSOCIATED VIRAL VECTORS USEFUL IN TREATMENT OF SPINAL MUSCULAR ATROPY

Ferritin nanoparticle compositions and methods to modulate cell activity

Methods and compositions for treating disorders and diseases using Survival Motor Neuron (SMN) protein

Compositions and methods for inhibiting intercellular interactions

Methods for reducing cardiotoxicity from chemotherapy by administering humanin analog compositions

Compositions and methods using a polyphenol for musculoskeletal health

METHOD FOR MODULATING APPETITE

Cysteine Peptide-Containing Health Drink

HAPTOGLOBIN DERIVATIVE FOR TREATMENT OF SEPSIS AND ACETAMINOPHEN-INDUCED LIVER DAMAGE

Use of CDK inhibitors to enhance growth and self-renewal of progenitor cells

Cell populations, methods of transdifferentiation and methods of use thereof

MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8 REGULATES FATTY ACID UPTAKE

Methods and compositions for treatment of disorders with follistatin polypeptides

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

Tumor suppressor REC8 as a biomarker for gastric cancer

USE OF COMPLEMENT PATHWAY INHIBITORS TO TREAT OCULAR DISEASES

Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same

Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR

Method for modulating insulin-independent glucose transport using teneurin C-terminal associated peptide (TCAP)

Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer

Translatable molecules and synthesis thereof

Histatins and method of use thereof

Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient

Targeting proteins for degradation

Fatty acids and their use in conjugation to biomolecules

Neuroprotective peptides

Methods and compositions for modulating PD1

Polypeptide-polymer conjugates and methods of use thereof

METHODS USING WHEY PROTEIN TO IMPROVE OR MAINTAIN MUSCLE QUALITY

Modulation of ciliogenesis

Methods for treatment of charcot-marie-tooth disease with follistatin polypeptides

Soluble MANF in pancreatic beta-cell disorders

Method of inducing cardiomyocytes proliferation and treating heart diseases

METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

Polypeptide

METHODS FOR TREATING REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS

Human skin equivalents expressing exogenous polypeptides

Prostate-targeting adeno-associated virus serotype vectors

METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION

Chemically ligated RNAs for CRISPR/Cas9-1gRNA complexes as antiviral therapeutic agents

Method for treating a muscle-related disorder with follistatin-related fusion proteins

Follistatin in treating duchenne muscular dystrophy

Modified Tamm-Horsfall protein and related compositions and methods of use

Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum

Glycotargeting therapeutics

Therapeutic compositions and methods for treatment of muscle wasting diseases

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

ENGINEERED INTEGRIN BINDING PEPTIDE COMPOSITIONS

Inhibition of cytokine-induced SH2 protein in NK cells

Treatment of cancer using chimeric antigen receptor and protein kinase a blocker

THERAPEUTIC PEPTIDES

Compositions for treating heart disease by inhibiting the action of mAKAP-β

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

BTNL9 AND ERMAP AS NOVEL INHIBITORS OF THE IMMUNE SYSTEM FOR IMMUNOTHERAPIES

TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH ONE OR MORE THERAPEUTIC AGENTS

Infant formula with special lipid architecture for promoting healthy growth

Therapeutic and diagnostic methods and compositions for neurodegenerative diseases

ETS factors regulate neural stem cell depletion and gliogenesis in Ras pathway glioma

Human-derived ferritin monomer fragment and fusion polypeptide using same

MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF

Diagnosis and treatment of preeclampsia

Neutralizing antibodies and methods of use thereof

Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease

Peptides

Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER

RASAL1 is a major tumor suppressor gene in thyroid cancer

Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons

Method and composition for treatment of hair loss

MECP2E1 gene

RNA preparations comprising purified modified RNA for reprogramming cells

A COMPOSITION OF GOLD NANOPARTICLES HAVING ANTIMICROBIAL PEPTIDES BOUND ON THEIR SURFACE FOR USE THE TREATMENT OF WOUND HEALING OR IN THE TREATMENT OF ISCHEMIC OR VASCULAR DISEASES OR IN THE TREATMENT OF SKIN DISORDERS

Biomarkers for seizures

Codon-optimized CFTR MRNA

PROTECTION AND SEALING OF THE OCULAR SURFACE BARRIER BY CLUSTERIN

SRPX for treatment of cancer

PROTECTION AGAINST AND TREATMENT OF IONIZING RADIATION

H3T3A mutant protein efficiently reduces H3T3P and causes increased cell death of rapidly dividing cells

CLATHRIN THERAPEUTIC FOR NEUROPSYCHIATRIC DISEASES & DISORDERS

CLATHRIN THERAPEUTIC FOR PSYCHIATRIC DISORDERS

Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c

Combination immunotherapy for the treatment of cancer

MULTIMERIZATION TECHNOLOGIES

Compositions and methods for protecting the kidney from ischemia reperfusion injury

Methods, compounds and compositions for modulating blood brain barrier integrity and re-myelination

Therapeutic compositions

Tumor suppressor SALL1 as a therapeutic agent for treating cancer

BIOACTIVE POLYMER FOR BONE REGENERATION

Inhibitor of IGFBP3/TMEM219 axis and diabetes

Medicine for treatment and/or prevention of ischemic diseases, method for improving angiogenesis-promoting activity of cells, or method for producing medicine

Method for expansion of a population of cells with IL2R beta/common gamma chain antibodies

Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof

DNA vaccines encoding heat shock proteins

PROTEIN THERAPY FOR TREATMENT OF RETINAL DISEASES

Isoform Nell-1 peptide

Reelin rescues cognitive function

Peptide regulators of JNK family kinases

Compositions and methods for treating graft versus host disease

Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders

ANTIBODY

Notch inhibition in the treatment and prevention of nonalcoholic fatty liver disease

Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof

Selective recovery

Dry powder inhaler and system for drug delivery

Method of treating leukemia utilizing somatic cell reprogramming

COMPOSITIONS AND METHODS FOR USING ANTI-IL-34 ANTIBODIES TO TREAT NEUROLOGICAL DISEASES

Progranulin (PGRN) fragments and derivatives for treatment or alleviation of lysosomal storage diseases

deletion mutants, non-yeast vectors encoding deletion mutants, and their use

Use of human small leucine zipper protein in osteogenesis procedure

INHIBITION OF BONE LOSS AND INHIBITION OF ARTHRITIS BY CTHRC1

METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES

Methods and products related to glutaminase inhibitors

Methods and compositions for treating genetically linked diseases of the eye

Peptidylic inhibitors targeting C9ORF72 hexanucleotide repeat-mediated neurodegeneration

Compositions and Treatments of Metabolic Disorders Using FGF Binding Protein 3

Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

PROTOCOL FOR HEALTH REHABILITATION

IL-2R beta/common gamma chain antibodies

NON-ALCOHOLIC FATTY LIVER REGULATING FACTOR 14-3-3 PROTEIN

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

Compositions and methods for regulating leukocyte adhesion

INHIBITION OF CANCER GROWTH AND METASTASIS

Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics

PROTEIN COATING COMPOSITION

HDL THERAPY MARKERS

Methods of treating pain using anti-GPR160 antibodies

Wound Treatment

Methods and compositions for treating trinucleotide repeat disorders

Nanoparticulate compositions comprising interferon gamma and losartan for immunotherapy

Angiopoietin-like 4 and a method of its use in wound healing

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Engineered endothelial cells expressing an ETS transcription factor

Peptides and compositions for treatment of joint damage

Immunotherapy against melanoma and other cancers

Methods for identification, assessment, prevention, and treatment of metabolic disorders using Slit2

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

WNT compositions and methods for purification

METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE

EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE

IMMUNE CHECKPOINT CHIMERIC ANTIGEN RECEPTORS THERAPY

Compositions and methods to improve exercise performance and recovery

Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection

Use of Hsp70 as a regulator of enzymatic activity

Nutritional supplement composition suitable for improving lean tissue mass status in an adult human

Reduction of lipase activity in product formulations

FcRn antagonists and methods of use

Medical devices, systems, and methods utilizing antithrombin-heparin composition

Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases

DIAGNOSTIC TARGET

New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Mild Cognitive Impairment

Methods for enhancing antigen-specific immune responses

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALNUTRITION

Beta-casein A2 and antioxidant capacity

TRIM11 for degradation of protein aggregates

Exosomes and their use as vaccine

Controlled release system for pulmonary delivery of surfactant protein D

Methods and Related Kits for Treating and Regenerating Tooth Pulp and Periapical Tissues in a Mammal

PRG4 FOR TREATING GOUT AND ITS SYMPTOMS

R-SPONDIN AGONIST-MEDIATED HAIR GROWTH

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

ESSENTIAL NUTRIENTS AND RELATED METHODS

C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

Synergistic combination of neuronal viability factors and uses thereof

Composition comprising KA11 polypeptide or gene encoding the same for inhibiting angiogenesis, and use thereof

COMPOSITIONS AND METHODS FOR TREATING POST OPERATIVE COGNITIVE DYSFUNCTION AND NEUROINFLAMMATION WITH ANNEXIN A1 (ANXA1) PEPTIDES

Tau modulators and methods and compositions for delivery thereof

Treatment and diagnosis of melanoma

Application and uses of PRG4 and therapeutic modulation thereof

Heat substrate and/or image enhancement compositions and enhanced tissue ablation methods

SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS

CARBON MATERIAL DELIVERY SYSTEMS AND METHODS

Oligopeptide having proinflammatory cytokine secretion-inhibiting activity

METHODS OF MESENCHYMAL STEM CELL MOBILIZATION AND EXPANSION

Anti-bacterial agents and their use in therapy

Enhancement of osteogenic potential of bone grafts

Frataxin expression constructs

Compositions and methods for enhancing peptide stability against protease digestion

Peptide inhibitors of twist

RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION

Use of PRG4 to improve dynamic visual acuity and higher order aberrations

METHODS FOR DIAGNOSING DISEASES ASSOCIATED WITH HUMAN SIGNAL PEPTIDE-CONTAINING MOLECULES

XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE PEPTIDES, AND METHODS OF USING SUCH PEPTIDES AND COMPOSITIONS

NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC

Compositions and methods for treating diabetes, hypertension and hypercholesterolemia

IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Ice-based lipid nanoparticle formulation for delivery of mRNA

METHOD OF TREATING NEOPLASIAS

INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE

Modified binding proteins inhibiting the VEGF-A receptor interaction

RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS

Treatment with methylation-controlled J protein (MCJ)

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Human catestatin induces gut microbiota dysbiosis

COMPOSITIONS COMPRISING RECEPTOR-ASSOCIATED PROTEIN (RAP) VARIANTS SPECIFIC FOR CR-CONTAINING PROTEINS AND USES THEREOF

USE OF IMMUNESUPPRESSANT RECEPTOR

Method to produce an immunoglobulin preparation with improved yield

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Compositions and methods of improved wound healing